Intracranial Aneurysm as a Macrophage-mediated Inflammatory Disease

Area of Science:

• Neuroscience
• Immunology
• Vascular Biology

Background:

• Subarachnoid hemorrhage (SAH) often results from ruptured intracranial aneurysms (IAs).
• Current treatments for SAH have limited efficacy, highlighting the need for preventative strategies.
• Understanding IA pathogenesis is crucial for developing preemptive medicine.

Purpose of the Study:

• To explore the role of macrophage-mediated inflammation in the development and progression of intracranial aneurysms.
• To investigate potential therapeutic targets for preventing SAH by modulating inflammatory responses.

Main Methods:

• Histopathological analysis of human IA lesions and animal models.
• Genetic manipulation (deletion) of key inflammatory mediators and macrophage-related genes in animal models.
• Pharmacological depletion of macrophages in animal models.

Main Results:

• Macrophage infiltration in IA lesions correlates positively with IA enlargement and rupture.
• Inhibition of monocyte chemotactic protein-1 and macrophage depletion suppressed IA development in animal models.
• Targeting specific macrophage pathways (Ptger2, NF-κB signaling) reduced IA formation.

Conclusions:

• Intracranial aneurysms are characterized by macrophage-mediated chronic inflammation.
• Modulating macrophage-driven inflammatory responses presents a promising therapeutic strategy for preventing SAH.
• Defining IAs as inflammatory diseases opens avenues for novel preemptive treatments.